Scientifically, menopause triggers a sharp drop in estrogen, leading to vulvovaginal atrophy (thinning and drying of tissues), while chronic stress activates the hypothalamic-pituitary-adrenal axis, inhibiting arousal pathways and diverting energy from reproduction to survival.[5][9] Key contributors include: Menopause and perimenopause: Estrogen drop thins vaginal tissues, reduces lubrication, and dampens libido by altering brain chemistry
Managing nausea is therefore a key part of managing fatigue
Conclusions To summarize, more than 19 years after exenatide's approval, newer once-weekly GLP-1 medicines like semaglutide and tirzepatide have shown long-term efficacy and safety for type 2 diabetes and obesity
At the same concentration, different copper compounds can exhibit different irritancy potential
A distinct category has the potential to improve disease visibility within electronic health records, enable accurate epidemiological tracking, facilitate reimbursement for multidisciplinary care (including enzyme replacement and nutrition therapy), and support the development of registries and clinical pathways tailored to this high-risk population